NEW YORK, Feb. 06, 2024 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Harpoon Therapeutics, Inc. (NASDAQ: HARP)’s sale to Merck for $23.00 per share in cash. If you are a Harpoon shareholder, click here to learn more about your rights and options.
Taro Pharmaceutical Industries Ltd. (NYSE: TARO)’s sale to Sun Pharmaceutical Industries Limited for $43.00 per share in cash. If you are a Taro shareholder, click here to learn more about your rights and options.
First Financial Northwest Bank, a wholly-owned subsidiary of First Financial Northwest, Inc. (NASDAQ: FFNW)’s, sale to Global Federal Credit Union. The proposed transaction is structured as a purchase and assumption agreement with Global purchasing substantially all assets and assuming substantially all liabilities of First Financial Northwest Bank for the all-cash consideration of $231.2 million, subject to certain adjustments. If you are a First Financial shareholder, click here to learn more about your rights and options.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com
